Fig. 1From: Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trialChanges in the markers of lipid metabolism. Comparison of a campesterol, c sitosterol, e lathosterol at 0 and 52 weeks and absolute change in b campesterol, d sitosterol, f lathosterol at 52 weeksBack to article page